Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.290
-0.030 (-2.27%)
At close: Sep 9, 2026, 4:00 PM EDT
1.290
0.00 (0.00%)
Pre-market: Sep 10, 2026, 6:49 AM EDT
Pacific Biosciences of California Employees
Pacific Biosciences of California had 485 employees as of December 31, 2025. The number of employees decreased by 90 or -15.65% compared to the previous year.
Employees
485
Change (1Y)
-90
Growth (1Y)
-15.65%
Revenue / Employee
$328,394
Profits / Employee
-$270,901
Market Cap
400.97M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 485 | -90 | -15.65% |
| Dec 31, 2024 | 575 | -221 | -27.76% |
| Dec 31, 2023 | 796 | 27 | 3.51% |
| Dec 31, 2022 | 769 | 41 | 5.63% |
| Dec 31, 2021 | 728 | 316 | 76.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orthofix Medical | 1,605 |
| Viemed Healthcare | 1,438 |
| Tactile Systems Technology | 1,086 |
| NeuroPace | 220 |
| Sight Sciences | 186 |
| 908 Devices | 172 |
| ClearPoint Neuro | 172 |
| Perspective Therapeutics | 166 |
PACB News
- 23 hours ago - PacBio assumed with a Neutral at UBS - TheFly
- 6 days ago - PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Pacific Biosciences of California Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 5 weeks ago - PacBio CEO Christian Henry steps down, Mark Van Oene succeeds - TheFly
- 5 weeks ago - PacBio cuts FY26 revenue view to $155M-$165M from $165M-$175M - TheFly
- 5 weeks ago - Pacific Biosciences of California Earnings Call Transcript: Q2 2026 - Transcripts
- 5 weeks ago - Pacific Biosciences of California Slides: Q2 2026 - Filings
- 5 weeks ago - Pacific Biosciences of California Earnings release: Q2 2026 - Filings